Most Recent

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: FDA Considers Three-Parent IVF

FDA Considers Three-Parent IVF

By | October 17, 2013

The US regulatory agency will meet next week to discuss whether to allow human trials of a technique that combines the genetic information of three adults.

0 Comments

image: A New Antibiotic?

A New Antibiotic?

By | October 16, 2013

Scientists show that peptide-conjugated phosphorodiamidate morpholino oligomers can effectively silence essential bacterial genes.

4 Comments

image: Fighting Viruses with RNAi

Fighting Viruses with RNAi

By | October 10, 2013

The long-debated issue of whether mammals can use RNA interference as an antiviral defense mechanism is finally put to rest.

0 Comments

image: Mislabeled Microbes Cause Two Retractions

Mislabeled Microbes Cause Two Retractions

By | October 10, 2013

Two papers on plant immunity have been retracted, and questions remain about others with similar results. 

9 Comments

image: Centipede Venom Tops Morphine

Centipede Venom Tops Morphine

By | October 1, 2013

The substance targets the same ion channel that's mutated in people who don't feel pain.

0 Comments

image: Speaking of Science

Speaking of Science

By | October 1, 2013

October 2013's selection of notable quotes

0 Comments

image: New Organelle: The Tannosome

New Organelle: The Tannosome

By | September 23, 2013

Researchers identify a structure in plants responsible for the production of tannins.

1 Comment

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Inducing Pluripotency Every Time

Inducing Pluripotency Every Time

By | September 18, 2013

By removing a single gene, adult cells can be reprogrammed into a stem-like state with nearly 100 percent efficiency.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham